After his diagnosis with extensive stage small cell lung cancer, Marcus leaned on his community while exploring treatment ...

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan ...

The prognostic landscape for older adults with acute lymphoblastic leukemia (ALL) has shifted dramatically in recent years, according to Emily K. Curran, MD, associate professor o ...

An analysis of more than 250,000 older adults diagnosed with metastatic non-small cell lung cancer showed only about half ...

Cancer is one of the most feared diseases in the world because of its ability to grow and spread throughout the body. It ...

Application includes updated TRUST-I TKI-naïve median duration of response (mDOR) and median progression-free survival (mPFS) of more than 4 years, as well as TRUST-II ...

Achieved $18.5 million in first quarter of 2026 net product revenues for IBTROZI® (taletrectinib); majority of the approximately 200 patients started on IBTROZI in ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the first quarter ended March 31, 2026, and ...

Michael Armishaw was diagnosed with pancreatic cancer, which didn't show a single symptom until it was stage 4 ...

Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating ...

With multiple options for ROS1-positive NSCLC, the next challenge will be figuring out which drug works best for lung cancer ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced results from a pooled analysis of long-term follow-up data from ...